MSB 0.38% $1.32 mesoblast limited

Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment, page-30

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 693 Posts.
    lightbulb Created with Sketch. 266
    Oh, and since I'm obviously a shorter I'll throw in another BTW for good measure.

    Today's announcement states that the milestone was completed "on plan". I'm assuming that means, amongst other things in the plan, it was on time. Funny because in June 16 the timing was 18 months, so they're about a year behind. And if you go back a few years before it was even earlier.

    The point of that? Well one of the reasons the share price is so low given so much potential (and I acknowledge the potential) is that people no longer trust the announcements - eg claiming reduced trial sizes despite increase, post-hoc analyses, missed deadlines, claiming success for failed endpoints, etc etc.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.005(0.38%)
Mkt cap ! $1.478B
Open High Low Value Volume
$1.31 $1.32 $1.28 $977.1K 754.2K

Buyers (Bids)

No. Vol. Price($)
15 7978 $1.31
 

Sellers (Offers)

Price($) Vol. No.
$1.32 15147 5
View Market Depth
Last trade - 12.29pm 01/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.